FDA Inspection 1293390 — Delaware Institute For Reproductive Medicine, P.A
The FDA completed an inspection of Delaware Institute For Reproductive Medicine, P.A on Sep 16, 2025 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Newark, DE (United States)